High-Risk Retinoblastoma Based on International Classification Systems
Ophthalmology Retina · 2025-08 · 9 (8) · 787-797
DOI: 10.1016/j.oret.2025.01.020 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Ophthalmology Retina, 2025-08. Verfasst von Deepthi E Kurian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Retinoblastoma, Retinal Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania.
- Ocular Oncology Service, LV Prasad Eye Institute, Hyderabad, India.
- Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address: carolshields@gmail.com.
Zitieren
APA
Kurian, D. E., Kaliki, S., Shields, C. L., & High-Risk Retinoblastoma Collaborative Group (2025). High-Risk Retinoblastoma Based on International Classification Systems. Ophthalmology Retina, 9(8), 787-797. https://doi.org/10.1016/j.oret.2025.01.020
Vancouver
Kurian DE, Kaliki S, Shields CL, High-Risk Retinoblastoma Collaborative Group. High-Risk Retinoblastoma Based on International Classification Systems. Ophthalmology Retina. 2025;9(8):787-797. doi:10.1016/j.oret.2025.01.020
BibTeX
@article{Kurian2025,
author = {Kurian, Deepthi E and Kaliki, Swathi and Shields, Carol L and High-Risk Retinoblastoma Collaborative Group, High-Risk Retinoblastoma Collaborative Group},
title = {High-Risk Retinoblastoma Based on International Classification Systems},
journal = {Ophthalmology Retina},
year = {2025},
volume = {9},
number = {8},
pages = {787--797},
doi = {10.1016/j.oret.2025.01.020}
}
EUVIMED